CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Dongsung Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Dongsung Pharmaceutical Co Ltd
Dongsung Bldg.
683, Dobong-ro, Dobong-gu
Phone: +82 269113600p:+82 269113600 SEOUL, 01340  South Korea Ticker: 002210002210
Filed for Rehabilitation on 5/7/2025
On 5/7/2025, Dongsung Pharmaceutical Co Ltd filed for the commencement of Rehabilitation Proceedings with the Seoul Bankruptcy Court.
Business Summary
Dongsung Pharmaceutical Co Ltd is a Korea-based company primarily engaged in the manufacturing and sales of pharmaceuticals business. The Company is mainly engaged in the manufacturing and sales of medicines used in the treatment of diarrhea, indigestion, hair loss, pain and anti-inflammatory drugs. In addition, the Company is engaged in the manufacturing and sales of hair dye, cosmetics, sanitary pads, lactic acid bacteria and household chemical products. The Company sells its products in domestic and overseas markets.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2844 Perfumes, cosmetics, and other toilet preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Yang GuLee 51
Vice Chairman Yeon SuKim 72 12/31/2005 12/31/2005
Vice President, Director Jung MuGwon 66 3/21/2008 3/21/2008
5 additional Officers and Directors records available in full report.

Business Names
Business Name
002210
Dongsung Pharmaceutical Co., Ltd.

General Information
Number of Employees: 314 (As of 6/30/2025)
Outstanding Shares: 24,408,359 (As of 6/30/2025)
Shareholders: 20,182
Stock Exchange: KRX
Fax Number: +82 234920231


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, September 14, 2025